- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Asthma; Chronic obstructive pulmonary disease (COPD)
- Meeting Date: November 2019
- Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)
Salbutamol – November 2019
Salbutamol: Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses (CFC-free formulation); Ventolin®
Last updated
6 March 2020